Double Take explores what happens to health care investing and financing now that curative genes can be delivered to patients.
Stay up to date on what's impacting the world of investing. Newton's Double Take podcast pairs industry experts with Newton's investment professionals to discuss the top-of-mind issues shaping the economic landscape. From shifting geopolitics to impact investing and 5G, get perspective from two sides on complex issues. Learn more at: www.newtonim.com/double-take-podcast Disclosures Newton Investment Management (“Newton”) is a registered investment advisor and subsidiary of The Bank of New York Mellon Corporation (“BNY Mellon”). Any statements of opinion constitute only current opinions of Newton, which are subject to change and which Newton does not undertake to update. This publication or any portion thereof may not be copied or distributed without prior written approval from the firm. Statements are correct as of the date of the material only. This document may not be used for the purpose of an offer or solicitation in any jurisdiction or in any circumstances in which such offer or solicitation is unlawful or not authorized. The information in this publication is for general information only and is not intended to provide specific investment advice or recommendations for any purchase or sale of any specific security. Some information contained herein has been obtained from third party sources that are believed to be reliable, but the information has not been independently verified by Newton. Newton makes no representations as to the accuracy or the completeness of such information. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment and past performance is no indication of future performance. The indices referred to herein are used for comparative and informational purposes only and have been selected because they are generally considered to be representative of certain markets. Comparisons to indices as benchmarks have limitations because indices have volatility and other material characteristics that may differ from the portfolio, investment or hedge to which they are compared. The providers of the indices referred to herein are not affiliated with Newton, do not endorse, sponsor, sell or promote the investment strategies or products mentioned herein and they make no representation regarding the advisability of investing in the products and strategies described herein. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. BNY Mellon Privacy Notice: https://www.bnymellon.com/us/en/data-privacy.html. For more market perspectives and insights from our teams, please visit www.newtonim.com. Double Take was previously published by Mellon Investments Corporation. On September 1, 2021, all of Mellon Investments Corporation's active equity and multi-asset strategies were transferred to Newton Investment Management North America LLC.